It this podcast we talk to Nils Bolstad about two randomized controlled trials (RCTs) for therapeutic drug monitoring (TDM) of infliximab published in JAMA in 2021. Both studies can be found in the IFCC Outcome study database (paper I, paper II).
Username or Email Address
Password
Remember Me
